Skip to main content

Table 2 Summary of extracted categorical primary care data overall and by CCG

From: Increasing uptake of structured self-management education programmes for type 2 diabetes in a primary care setting: a feasibility study

Variable

N (%)

All (N = 2877)

CCG 1 (N = 1036)

CCG 2 (N = 1841)

Sex

 Male

1588 (55.2)

575 (55.5)

1013 (55.0)

 Female

1289 (44.8)

461 (44.5)

828 (45.0)

Ethnicity

 White European

1948 (67.7)

618 (59.7)

1330 (72.2)

 South Asian

219 (7.6)

56 (5.4)

163 (8.9)

 Black

57 (2.0)

5 (0.5)

52 (2.8)

 Other

32 (1.1)

12 (1.2)

20 (1.1)

 Not otherwise stated

121 (4.2)

102 (9.9)

19 (1.0)

 Missing

500 (17.4)

243 (23.5)

257 (14.0)

Smoking status

 Never smoker

1425 (49.5)

508 (49.0)

917 (49.8)

 Ex-smoker

1102 (38.3)

435 (42.0)

667 (36.2)

 Current smoker

350 (12.2)

93 (9.0)

257 (14.0)

HbA1c, mmol/mol (%)

 ≤ 53 (≤ 7%)

1465 (50.9)

585 (56.5)

880 (47.8)

 54–58 (7.1–7.5%)

385 (13.4)

148 (14.3)

237 (12.9)

 59–64 (7.6–8.0%)

279 (9.7)

100 (9.7)

179 (9.7)

 65–69 (8.1–8.5%)

152 (5.3)

58 (5.6)

94 (5.1)

 70–86 (8.6–10.0%)

266 (9.3)

83 (8.0)

183 (9.9)

 ≥ 87 (≥ 10.1%)

141 (4.9)

40 (3.9)

101 (5.5)

 Missing

189 (6.6)

22 (2.1)

167 (9.1)

Diabetes medication in the last 12 months

 None recorded

639 (22.2)

215 (20.8)

424 (23.0)

 DPP-IV

101 (3.5)

22 (2.1)

79 (4.3)

 GLP-I

20 (0.7)

10 (1.0)

10 (0.5)

 Insulin

263 (9.1)

80 (7.7)

183 (9.9)

 Metformin

1425 (49.5)

559 (54.0)

866 (47.0)

 SGLT-2

21 (0.7)

5 (0.5)

16 (0.9)

 Sulphonylurea

346 (12.0)

136 (13.1)

210 (11.4)

 Multiple diabetes medications

38 (1.3)

0 (0.0)

38 (2.1)

 Other

24 (0.8)

9 (0.9)

15 (0.8)

Previous atrial fibrillation diagnosis

 Yes

246 (8.6)

106 (10.2)

140 (7.6)

 No

2631 (91.5)

930 (89.8)

1701 (92.4)

SSME referral

 No record

1809 (62.9)

546 (52.7)

1263 (68.6)

 DESMOND

586 (20.4)

106 (10.2)

480 (26.1)

 X-PERT

2 (0.1)

0 (0.0)

2 (0.1)

 DAFNE

18 (0.6)

2 (0.2)

16 (0.9)

 Generic SSME code

462 (16.1)

382 (36.9)

80 (4.4)

Date of SSME referral

 ≤ 1 year

270 (9.4)

138 (13.3)

132 (7.2)

 > 1 year

798 (27.7)

352 (34.0)

446 (24.2)

 Missing

1809 (62.9)

546 (52.7)

1263 (68.6)

SSME attendance

 Not referred

1317 (45.8)

311 (30.0)

1006 (54.6)

 Attendance not recorded

403 (14.0)

266 (25.7)

137 (7.4)

 Did not attend

744 (25.9)

395 (38.1)

349 (19.0)

 Attended

413 (14.4)

64 (6.2)

349 (19.0)

Date of SSME attendance

 ≤ 1 year

121 (4.2)

12 (1.2)

108 (5.9)

 > 1 year

291 (10.1)

52 (5.0)

239 (13.0)

 Missing

2465 (85.7)

972 (93.8)

1493 (81.1)

  1. CCG clinical commissioning goup, SSME structured self-management education, DPP-IV dipeptidyl peptidase 4, GLP-I glucagon-like peptide-1, SGLT-2 sodium-glucose transport protein 2